Article
The novel autophagy inhibitor elaiophylin exerts antitumor activity against multiple myeloma with mutant TP53 in part through endoplasmic reticulum stress-induced apoptosis.
Cancer biology & therapy - 3 Aug 2017
Wang Gaoxiang, Zhou Pan, Chen Xing, Zhao Lei, Tan Jiaqi, Yang Yang, Fang Yong, Zhou Jianfeng
Abstract excerpt
Elaiophylin is a natural compound and a novel and potent inhibitor of late stage autophagy with outstanding antitumor activity in human ovarian cancer cells. However, the possible biologic effects and functional linkage between elaiophylin and multiple myeloma (MM) have not been explored. This study aimed to assess the effect of elaiophylin on MM cells with mutant TP53 and the possible molecular mechanism. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.